ClinicalTrials.govpublic full text
An Efficacy and Safety Study of Niraparib in Men With Metastatic Castration-Resistant Prostate Cancer and DNA-Repair Anomalies
prostatic neoplasms, prostate cancer, crpc, metastatic castrate-resistant prostate cancer, prostate neoplasm, galahad, niraparib, dna anomalies, dna defect, parp inhibitor, parpi, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 833045
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.